ACIU
Price
$3.99
Change
+$0.86 (+27.48%)
Updated
Oct 3 closing price
Capitalization
401.39M
40 days until earnings call
RLYB
Price
$0.56
Change
+$0.05 (+9.80%)
Updated
Oct 3 closing price
Capitalization
23.61M
32 days until earnings call
Interact to see
Advertisement

ACIU vs RLYB

Header iconACIU vs RLYB Comparison
Open Charts ACIU vs RLYBBanner chart's image
AC Immune SA
Price$3.99
Change+$0.86 (+27.48%)
Volume$1.07M
Capitalization401.39M
Rallybio
Price$0.56
Change+$0.05 (+9.80%)
Volume$935.78K
Capitalization23.61M
ACIU vs RLYB Comparison Chart in %
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACIU vs. RLYB commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACIU is a Buy and RLYB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 05, 2025
Stock price -- (ACIU: $3.99 vs. RLYB: $0.56)
Brand notoriety: ACIU and RLYB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACIU: 677% vs. RLYB: 234%
Market capitalization -- ACIU: $401.39M vs. RLYB: $23.61M
ACIU [@Biotechnology] is valued at $401.39M. RLYB’s [@Biotechnology] market capitalization is $23.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACIU’s FA Score shows that 0 FA rating(s) are green whileRLYB’s FA Score has 1 green FA rating(s).

  • ACIU’s FA Score: 0 green, 5 red.
  • RLYB’s FA Score: 1 green, 4 red.
According to our system of comparison, RLYB is a better buy in the long-term than ACIU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACIU’s TA Score shows that 7 TA indicator(s) are bullish while RLYB’s TA Score has 4 bullish TA indicator(s).

  • ACIU’s TA Score: 7 bullish, 3 bearish.
  • RLYB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ACIU is a better buy in the short-term than RLYB.

Price Growth

ACIU (@Biotechnology) experienced а +40.49% price change this week, while RLYB (@Biotechnology) price change was +2.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

ACIU is expected to report earnings on Nov 14, 2025.

RLYB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACIU($401M) has a higher market cap than RLYB($23.6M). ACIU YTD gains are higher at: 47.778 vs. RLYB (-41.156). RLYB has higher annual earnings (EBITDA): -43.29M vs. ACIU (-48.05M). ACIU has more cash in the bank: 127M vs. RLYB (45.7M). RLYB has less debt than ACIU: RLYB (58K) vs ACIU (4.92M). ACIU has higher revenues than RLYB: ACIU (28.9M) vs RLYB (761K).
ACIURLYBACIU / RLYB
Capitalization401M23.6M1,699%
EBITDA-48.05M-43.29M111%
Gain YTD47.778-41.156-116%
P/E RatioN/AN/A-
Revenue28.9M761K3,798%
Total Cash127M45.7M278%
Total Debt4.92M58K8,481%
FUNDAMENTALS RATINGS
ACIU: Fundamental Ratings
ACIU
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
85
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACIURLYB
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 17 days ago
88%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACIU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGI1.190.05
+4.39%
Birks Group
ECPG41.31-0.03
-0.07%
Encore Capital Group
EA200.69-0.31
-0.15%
Electronic Arts
RUN19.11-0.04
-0.21%
Sunrun
CBNA32.02-0.21
-0.65%
Chain Bridge Bancorp Inc

ACIU and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACIU has been loosely correlated with IMVT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ACIU jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACIU
1D Price
Change %
ACIU100%
+27.48%
IMVT - ACIU
40%
Loosely correlated
+1.02%
RGNX - ACIU
37%
Loosely correlated
-1.42%
CRBU - ACIU
37%
Loosely correlated
+1.79%
IRON - ACIU
36%
Loosely correlated
+2.92%
ARCT - ACIU
36%
Loosely correlated
+3.11%
More

RLYB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with PROK. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then PROK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
+10.42%
PROK - RLYB
44%
Loosely correlated
-1.44%
PXXLF - RLYB
44%
Loosely correlated
N/A
ATXS - RLYB
39%
Loosely correlated
-2.21%
ARTV - RLYB
37%
Loosely correlated
N/A
ACIU - RLYB
36%
Loosely correlated
+27.48%
More